Balanced news tone
News Sentiment
BNN sentiment intelligence
BRAIN Biotech AG news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
50
Balanced news tone
4 relevant articles
News tone and price action are not far from neutral.
80/100 classification confidence.
directly relevant articles
high-authority source matches
-3.4% over one week, -2.4% over four weeks, trend active, and near fair-value range.
Analysts Expect Breakeven For BRAIN Biotech AG (ETR:BNN) Before Long
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
80/100 classification
One-week reaction
-3.4%
Price reacting lower
Trend fit
Trend active
-2.4% over four weeks
Fair value
-1.8%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
0
Neutral
4
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
simplywall.st
Direct company coverage
Analysts Expect Breakeven For BRAIN Biotech AG (ETR:BNN) Before Long
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jan 2026 08:00
- Source
- simplywall.st
GlobeNewswire
Direct company coverage
Corbion and BRAIN Biotech team to shape the future of innovation in nature-based ingredient technologies
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Aug 2025 07:00
- Source
- GlobeNewswire
Bioökonomie.de
Direct company coverage
Brain Biotech acquires Breatec and Comix
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Feb 2022 08:00
- Source
- Bioökonomie.de
Universiteit Leiden
Direct company coverage
BRAIN appoints University of Leiden as partner for BEC-Enabled production strain development
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Sep 2021 07:00
- Source
- Universiteit Leiden